Analystreport

Evofem Biosciences, Inc. (NASDAQ: EVFM) had its price target lowered by analysts at HC Wainwright from $2.50 to $2.00. They now have a "buy" rating on the stock.

Evofem Biosciences, Inc.  (EVFM) 
Last evofem biosciences, inc. earnings: 3/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: evofem.com